These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32389535)

  • 1. Immune Modulation of Monocytes Dampens the IL-17
    Pinget GV; Tan J; Niewold P; Mazur E; Angelatos AS; King NJC; Macia L
    J Invest Dermatol; 2020 Dec; 140(12):2398-2407.e1. PubMed ID: 32389535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
    J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model.
    Choi CW; Kim BR; Yang S; Kim Y; Kang JS; Youn SW
    J Dermatol Sci; 2020 Jun; 98(3):199-202. PubMed ID: 32451152
    [No Abstract]   [Full Text] [Related]  

  • 6. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation.
    Matsumoto R; Dainichi T; Tsuchiya S; Nomura T; Kitoh A; Hayden MS; Ishii KJ; Tanaka M; Honda T; Egawa G; Otsuka A; Nakajima S; Sakurai K; Nakano Y; Kobayashi T; Sugimoto Y; Kabashima K
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yinxie I Formula attenuates imiquimod-induced psoriasis-like skin inflammation via IL-23/IL-17 axis.
    Yanping H; Ting G; Xinzhu Z; Yaya L; Yuna Z; Qing L; Xueli M; Jing C
    Arch Dermatol Res; 2024 Aug; 316(8):540. PubMed ID: 39158742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.
    Shi Z; Wu X; Yu S; Huynh M; Jena PK; Nguyen M; Wan YY; Hwang ST
    J Invest Dermatol; 2020 Sep; 140(9):1815-1823. PubMed ID: 32057839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
    McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
    Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
    Chen Y; Yan Y; Liu H; Qiu F; Liang CL; Zhang Q; Huang RY; Han L; Lu C; Dai Z
    Theranostics; 2020; 10(23):10466-10482. PubMed ID: 32929360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
    Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
    Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
    Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
    J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
    Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
    J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent fasting alleviates IMQ-induced psoriasis-like dermatitis via reduced γδT17 and monocytes in mice.
    Chen X; Fu C; Zheng Y; Li X; Liao Y; Zheng Y; Liang W; Zhao Y; Huang J; Huang T; Bu J; Shen E
    Arch Dermatol Res; 2024 May; 316(5):176. PubMed ID: 38758283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.